Literature DB >> 9109427

1,25 dihydroxyvitamin D3 stimulates phospholipase C-gamma in rat colonocytes: role of c-Src in PLC-gamma activation.

S Khare1, M J Bolt, R K Wali, S F Skarosi, H K Roy, S Niedziela, B Scaglione-Sewell, B Aquino, C Abraham, M D Sitrin, T A Brasitus, M Bissonnette.   

Abstract

Our laboratory has previously demonstrated that 1,25-dihydroxyvitamin D3 (1,25[OH]2D3) rapidly stimulated polyphosphoinositide (PI) hydrolysis, raised intracellular Ca2+, and activated two Ca2+-dependent protein kinase C (PKC) isoforms, PKC-alpha and -betaII in the rat large intestine. We also showed that the direct addition of 1,25(OH)2D3 to isolated colonic membranes failed to stimulate PI hydrolysis, but required secosteroid treatment of intact colonocytes, suggesting the involvement of a soluble factor. Furthermore, this PI hydrolysis was restricted to the basal lateral plasma membrane of these cells. In the present studies, therefore, we examined whether polyphosphoinositide-phospholipase C-gamma (PI-PLC-gamma), a predominantly cytosolic isoform of PI-PLC, was involved in the hydrolysis of colonic membrane PI by 1,25(OH)2D3. This isoform has been shown to be activated and membrane-associated by tyrosine phosphorylation. We found that 1,25(OH)2D3 caused a significant increase in the biochemical activity, particulate association, and the tyrosine phosphorylation of PLC-gamma, specifically in the basal lateral membranes. This secosteroid also induced a twofold increase in the activity of Src, a proximate activator of PLC-gamma in other cells, with peaks at 1 and 9 min in association with Src tyrosine dephosphorylation. 1,25(OH)2D3 also increased the physical association of activated c-Src with PLC-gamma. In addition, Src isolated from colonocytes treated with 1,25(OH)2D3, demonstrated an increased ability to phosphorylate exogenous PLC-gamma in vitro. Inhibition of 1,25(OH)2D3-induced Src activation by PP1, a specific Src family protein tyrosine kinase inhibitor, blocked the ability of this secosteroid to stimulate the translocation and tyrosine phosphorylation of PLC-gamma in the basolateral membrane (BLM). Src activation was lost in D deficiency, and was reversibly restored with the in vivo repletion of 1,25(OH)2D3. These studies demonstrate for the first time that 1,25(OH)2D3 stimulates PLC-gamma as well as c-Src in rat colonocytes, and indicate that PLC-gamma is a direct substrate of secosteroid-activated c-Src in these cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9109427      PMCID: PMC508007          DOI: 10.1172/JCI119350

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

1.  Blood platelets express high levels of the pp60c-src-specific tyrosine kinase activity.

Authors:  A Golden; S P Nemeth; J S Brugge
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

2.  Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis.

Authors:  D W Cleveland; S G Fischer; M W Kirschner; U K Laemmli
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

3.  A rapid, sensitive, and specific method for the determination of protein in dilute solution.

Authors:  W Schaffner; C Weissmann
Journal:  Anal Biochem       Date:  1973-12       Impact factor: 3.365

4.  The Src family tyrosine kinases are required for platelet-derived growth factor-mediated signal transduction in NIH 3T3 cells.

Authors:  G M Twamley-Stein; R Pepperkok; W Ansorge; S A Courtneidge
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

5.  Protein-lipid interactions in antipodal plasma membranes of rat colonocytes.

Authors:  T A Brasitus; R S Keresztes
Journal:  Biochim Biophys Acta       Date:  1984-06-27

6.  A protective role of 1,25-dihydroxyvitamin D3 in chemically induced rat colon carcinogenesis.

Authors:  A Belleli; S Shany; J Levy; R Guberman; S A Lamprecht
Journal:  Carcinogenesis       Date:  1992-12       Impact factor: 4.944

7.  Phospholipase C-gamma 1 associates with viral and cellular src kinases.

Authors:  O Nakanishi; F Shibasaki; M Hidaka; Y Homma; T Takenawa
Journal:  J Biol Chem       Date:  1993-05-25       Impact factor: 5.157

8.  Characterization of phosphoinositide-specific phospholipase C in rat colonocyte membranes.

Authors:  M J Bolt; B M Bissonnette; R K Wali; S C Hartmann; T A Brasitus; M D Sitrin
Journal:  Biochem J       Date:  1993-05-15       Impact factor: 3.857

9.  Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men.

Authors:  C Garland; R B Shekelle; E Barrett-Connor; M H Criqui; A H Rossof; O Paul
Journal:  Lancet       Date:  1985-02-09       Impact factor: 79.321

10.  Activation of the pp60c-src kinase by middle T antigen binding or by dephosphorylation.

Authors:  S A Courtneidge
Journal:  EMBO J       Date:  1985-06       Impact factor: 11.598

View more
  12 in total

Review 1.  The nonskeletal effects of vitamin D: an Endocrine Society scientific statement.

Authors:  Clifford J Rosen; John S Adams; Daniel D Bikle; Dennis M Black; Marie B Demay; JoAnn E Manson; M Hassan Murad; Christopher S Kovacs
Journal:  Endocr Rev       Date:  2012-05-17       Impact factor: 19.871

2.  Combined inhibition of PLC{gamma}-1 and c-Src abrogates epidermal growth factor receptor-mediated head and neck squamous cell carcinoma invasion.

Authors:  Hiroshi Nozawa; Gina Howell; Shinsuke Suzuki; Qing Zhang; Yanjun Qi; Judith Klein-Seetharaman; Alan Wells; Jennifer R Grandis; Sufi M Thomas
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

3.  Src couples estrogen receptor to the anticipatory unfolded protein response and regulates cancer cell fate under stress.

Authors:  Liqun Yu; Lawrence Wang; Ji Eun Kim; Chengjian Mao; David J Shapiro
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2020-06-02       Impact factor: 4.739

4.  Vitamin D receptor protein expression in tumor tissue and prostate cancer progression.

Authors:  Whitney K Hendrickson; Richard Flavin; Julie L Kasperzyk; Michelangelo Fiorentino; Fang Fang; Rosina Lis; Christopher Fiore; Kathryn L Penney; Jing Ma; Philip W Kantoff; Meir J Stampfer; Massimo Loda; Lorelei A Mucci; Edward Giovannucci
Journal:  J Clin Oncol       Date:  2011-05-02       Impact factor: 44.544

5.  In skeletal muscle advanced glycation end products (AGEs) inhibit insulin action and induce the formation of multimolecular complexes including the receptor for AGEs.

Authors:  Angela Cassese; Iolanda Esposito; Francesca Fiory; Alessia P M Barbagallo; Flora Paturzo; Paola Mirra; Luca Ulianich; Ferdinando Giacco; Claudia Iadicicco; Angela Lombardi; Francesco Oriente; Emmanuel Van Obberghen; Francesco Beguinot; Pietro Formisano; Claudia Miele
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

6.  Role of Fyn and PI3K in H2O2-induced inhibition of apical Cl-/OH- exchange activity in human intestinal epithelial cells.

Authors:  Seema Saksena; Ravinder K Gill; Sangeeta Tyagi; Waddah A Alrefai; Krishnamurthy Ramaswamy; Pradeep K Dudeja
Journal:  Biochem J       Date:  2008-11-15       Impact factor: 3.857

7.  Identification of c-Src tyrosine kinase substrates in platelet-derived growth factor receptor signaling.

Authors:  Ramars Amanchy; Jun Zhong; Rosa Hong; James H Kim; Marjan Gucek; Robert N Cole; Henrik Molina; Akhilesh Pandey
Journal:  Mol Oncol       Date:  2009-07-10       Impact factor: 6.603

8.  Role of tyrosine phosphorylation in ligand-induced regulation of transcytosis of the polymeric Ig receptor.

Authors:  F Luton; M H Cardone; M Zhang; K E Mostov
Journal:  Mol Biol Cell       Date:  1998-07       Impact factor: 4.138

9.  Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia.

Authors:  Guang-Sheng Lei; Chen Zhang; Michelle K Zimmerman; Chao-Hung Lee
Journal:  Antimicrob Agents Chemother       Date:  2015-12-14       Impact factor: 5.191

Review 10.  Very important pharmacogene summary for VDR.

Authors:  Audrey H Poon; Li Gong; Charlotte Brasch-Andersen; Augusto A Litonjua; Benjamin A Raby; Qutayba Hamid; Catherine Laprise; Scott T Weiss; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2012-10       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.